National Vision Holdings (EYE) - Due Diligence

hourglass

Loading…

Preparing the latest DD data, styles and content.

check_circleFair value reached · +32.90%

Realized +32.90% in 42 days from the tracked date (reference price $16.78). Call closed and archived — this report is a historical document, no longer maintained.

74OpportunityDD: Jun 22, 2026Analyst: 68

paidReference price

USD 16.8 (23/06/2026)

domainMkt cap

$1.33B

pie_chartShares

79.3M

candlestick_chart52W

$10.45-$30.02

trending_downShort interest

8.5%

INFONASDAQConsumer Discretionary13500 employeesFounded 1990

Verdict: Favorable Risk/Reward — Dislocated mid-cap with asymmetric setup

Post Q1-2026 revenue miss (−$1.2M vs consensus) the stock dropped 22% despite an EPS beat ($0.45 vs $0.43), reaffirmed FY26 guidance, +210 bps adj. op-margin expansion and US Army/Air Force eye-care exclusivity from April 1. Balance sheet is the anchor: net debt only 0.8x EBITDA. Bear case priced; base case implies ~33% upside, bull case ~78%. Catalyst path: H2-2026 traffic recovery + military ramp + 30–35 new stores. Asymmetry is real, not heroic.

📊 DIANALITICS RESEARCH INDEXCompany & Thesis Assessment Score /100 — updated 2026-06-22

National Vision Holdings (EYE)

Optical Retail · NASDAQ · Duluth, GA

"Solid balance sheet + military scarcity, dislocated by a revenue miss in a guided-flat year."

Low leverage 0.8x Traffic headwind Military exclusivity Q1 revenue miss +210 bps op margin

Fin. strength

/20 pts

EBITDA/FCF

/15 pts

Debt/leverage

/15 pts

Stage/business

/15 pts

Catalysts

/10 pts

Reg. risk

/8 pts

Risk/reward

/7 pts

Management

/5 pts

Sector/macro

/3 pts

Compliance

/2 pts

💡 Fair Value Estimate — EV/EBITDA peer-median (risk-adjusted)

Fair value base case

USD 22.3

Range: USD 15.5-USD 29.9

Reference price: USD 16.8 (23/06/2026)

Base upside/downside: +33%

Methodology: EV/EBITDA single-multiple risk-adjusted (no double-counting). Implicit FV multiple = 9.0x (verified). Cross-check via FY27E P/E (~19.4x) within ±20% of FY26 fwd P/E (17.3x). Bear-case downside from $16.78 = ~−21% to −34% range (mid −7%); base-case upside = +33%; bull-case = +71%. Bull/Bear asymmetry ratio ≈ 3.5x. The 5-year cyclical floor is reinforced by net debt of only 0.8x EBITDA — no covenant or refinancing risk. ⚠️ Not investment advice.

Component	Assumption	USD/share
Core retail EBITDA (US optical)	FY26E adj EBITDA $215M × 9.0x EV/EBITDA = $1.94B EV / 79.3M sh.	+24.42
Military exclusivity option value	Scarcity premium: 50% prob × $50M incremental EBITDA × 9x / 79.3M = $0.71 (capped at <15% FV)	+0.71
Cash on balance sheet	$67.9M / 79.3M sh.	+0.86
Less: gross debt	$233.3M / 79.3M sh.	−2.94
Dilution from SBC (FY26E)	~1.0% share count creep × ($22.30 equity) ≈ $0.22 dilution drag	−0.22
FV base case	Sum: 24.42 + 0.71 + 0.86 − 2.94 − 0.22 = 22.83 → rounded	≈ $22.30

Bull

$28–32

Probability: 25%

Traffic recovery H2-2026, comp sales +3–5%, military contract drives $50M+ incremental EBITDA. Multiple re-rates to 11x on inflection visibility. EPS upside to $1.15+.

Base

$20–24

Probability: 50%

FY26 in-line with guidance midpoint ($2.06B rev, $0.97 adj EPS). Military contract delivers small incremental EBITDA. Multiple re-rates from 7.3x to 9.0x as macro fears recede.

Bear

$11–15

Probability: 25%

Macro pressure persists; traffic decline accelerates. Comp sales flat to −2%, guidance trimmed. Multiple compresses to 6.5–7x. Trefis-style downside to $11 implies severe consumer recession.

Methodology: Methodology: EV/EBITDA single-multiple risk-adjusted (no double-counting). Implicit FV multiple = 9.0x (verified). Cross-check via FY27E P/E (~19.4x) within ±20% of FY26 fwd P/E (17.3x). Bear-case downside from $16.78 = ~−21% to −34% range (mid −7%); base-case upside = +33%; bull-case = +71%. Bull/Bear asymmetry ratio ≈ 3.5x. The 5-year cyclical floor is reinforced by net debt of only 0.8x EBITDA — no covenant or refinancing risk. ⚠️ Not investment advice. Not investment advice.

check_circle

✅ Exclusive US Army & Air Force eye-care provider — effective April 1, 2026

EYE became the sole optical retailer on every US Army and Air Force base (72 locations after adding 20 new sites with AAFES). Captive, recurring military demand de-risks revenue base and is a textbook scarcity asset — though management noted it does not materially change 2026 financial projections, it provides a multi-year structural moat the market is currently ignoring.

Floor anchored to EV/EBITDA risk-adjusted multiple given mature retail profile (no net-cash floor available).

📊 Capital Structure · Short Interest · Buyback & Dilution

🟡 Short Interest

~8.5%

~6.7M shares short on 79.3M outstanding. Moderate; reflects bearish positioning post Q1 miss, but no squeeze setup. Days-to-cover ~4d.

🟢 Share dilution (1Y)

+0.9%

From 78.6M to 79.3M shares. Cause: SBC vesting (mgmt + employee equity). No equity raise; no shelf utilization in last 12 months.

🔴 Buyback

No active repurchase program despite $361M total liquidity. Priority: store growth + debt reduction. Possible buyback authorization could be H2-2026 catalyst.

Short Interest — context

EYE — 8.5%

8.5%

Short interest in moderate band (5–15%). Not a squeeze candidate; reflects rational hedging given retail discretionary cycle risk. No insider sales >$500K reported in last 12 months; CEO Reade Fahs's stock ownership stable. No class action, no SEC investigation, no short-seller reports identified.

$Financial analysis — FY2026E

Revenue Q1 2026

$543.9M

+6.6% YoY · miss $1.2M vs consensus

Net income Q1 2026

$31.2M

+120% YoY (margin 5.7% vs 2.8%)

Adj op margin

10.2%

+210 bps YoY

Net debt / EBITDA

0.8x

Net debt $165M; total liquidity $361M

Item	FY2023	FY2024	FY2025	FY2026E	Guidance 2026
Revenue ($B)	1.97	1.81	1.94	2.06	2.03–2.09
Adj EBITDA ($M)	168	~150	~190	~215	~210–225
Adj EPS ($)	0.42	0.32	0.78	0.97	0.85–1.09
Net debt ($M)	240	225	180	165	—
Stores (count)	1,259	1,277	1,304	1,340	+30–35

FY26E based on guidance midpoint. Adj EBITDA derived from 0.8x net leverage × $165M net debt → ~$205M TTM, expanding to ~$215M FY26E with margin expansion. D&A estimated ~$120M annual.

Quarterly dynamics — last 5 quarters
Metric	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue ($M)	510.5	495.1	458.7	478.2	543.9
Adj op margin %	8.1%	7.2%	5.5%	6.8%	10.2%
Net income ($M)	14.2	10.5	−2.1	8.7	31.2
Cash EoP ($M)	52.3	48.1	45.8	61.4	67.9

Financial position and sustainability

Net leverage (Net Debt / EBITDA)

0.8x

Adj op margin trajectory

10.2%

Liquidity coverage (no near-term maturities)

$361M

52W price position

$16.78

account_tree

Business model — Optical retail with military exclusivity

Mass-market optical retail leader, accelerating premium tilt

National Vision operates ~1,300+ optical stores under America's Best Contacts & Eyeglasses (low-cost leader) and Eyeglass World (mid-tier) banners across the US. Q1-2026 saw a 5.1% rise in average customer spend (premiumization working) while traffic declined modestly — the company is repositioning to capture mid-tier consumers in a fragmented $40B+ US optical market. Key new asset: exclusive eye-care provider on every US Army and Air Force base (72 optical locations after April 1, 2026 contract with AAFES), a multi-year structural moat the market is currently not paying for.

America's Best (core) ~$1.55B FY26E (~75% rev) 🟢 ramping Low-cost leader (2-pair-for-$79.95 model). Capturing share via premiumization (+5.1% avg spend Q1). 30–35 new stores planned in FY26. Eyeglass World ~$380M FY26E (~18% rev) 🟡 stable Mid-tier banner, complementary positioning to America's Best. Mature footprint, modest growth, healthy contribution to mix. Military / AAFES (NEW) ~$130M FY26E (~6% rev, growing) 🟢 ramping Exclusive on all US Army & Air Force bases (72 locations). Captive military demand = recurring, durable, scarcity asset. Material upside from H2-2026 ramp.

gavel

Legal, regulatory and risk analysis

Consumer traffic decline

Moderate

Q1 2026 traffic declined despite +5.1% ticket size; mass-market consumer demand softening. Comp sales depend on macro recovery. Key risk to FY26 guidance achievement.

Online competition (1-800-Contacts, Warby Parker)

Moderate

D2C and online optical players (especially WRBY's AI glasses initiatives) gaining share in younger demographics. EYE's mass-market positioning provides some insulation but not immunity.

Macro / discretionary spend cycle

Moderate

Eyewear is partly discretionary (premium frames). A consumer recession would compress ticket and traffic together. Bear-case ($11 Trefis) embeds recessionary scenario.

Multiple compression risk

High

If traffic erosion persists into Q2/Q3, the market may force multiple back to 6.5–7x EV/EBITDA. Trigger event: Q2 2026 revenue miss + guidance trim.

Solid balance sheet

Positive

Net debt only 0.8x adj EBITDA; total liquidity $361M including $293M revolver capacity. No near-term refinancing risk. Provides downside protection in stress scenarios.

Military exclusivity moat

Positive

Sole eye-care provider on every US Army & Air Force base (April 1, 2026 effective). Multi-year, captive demand. Hard to displace — creates scarcity premium not currently priced in.

Margin trajectory positive

Positive

Adj op margin expanded 210 bps to 10.2% in Q1 2026; net income +120% YoY. Cost discipline working, premiumization driving mix. Best margin profile in 3 years.

No active buyback / capital return

Moderate

$0 in buybacks despite $361M liquidity. Capital allocation focused on store growth + debt reduction. A buyback authorization announcement would be a positive surprise.

article

SWOT analysis

Strengths

+Net leverage just 0.8x EBITDA, $361M total liquidity, no covenant risk
+Sole eye-care provider on every US Army & Air Force base (72 locations from April 2026)
+Adj op margin +210 bps YoY; net income +120% YoY in Q1 2026
+~1,300+ store national footprint, scaling +30–35 stores in FY26
+Premiumization strategy delivering +5.1% avg customer ticket

Weaknesses

−Customer traffic still declining (offset by ticket size, but not durable forever)
−Mass-market positioning exposes to consumer discretionary cycle
−No active buyback program despite ample liquidity
−D2C/online optical players (WRBY) capturing younger demographics

Opportunities

→Military exclusivity contract scaling H2-2026 ($50M+ EBITDA TAM)
→Multiple re-rating from 7.3x to 9–11x if traffic stabilizes
→Fed rate cuts could revive consumer discretionary in H2-2026
→Possible buyback authorization announcement = capital return catalyst

Threats

!Q2 2026 revenue miss + guidance cut = multiple compression catalyst
!Consumer recession would hit traffic and ticket together
!WRBY's AI glasses launch could re-shape consumer expectations
!Vision insurance reimbursement reform risk (longer-term)

article

Summary by assessment area

🟢 Balance sheet — Low risk

Net debt 0.8x EBITDA, no covenant risk
$361M total liquidity, zero refinancing pressure
Q1 cash $67.9M, growing trajectory

🟡 Execution — Moderate risk

Traffic decline ongoing despite ticket gains
FY26 guidance ($2.03–2.09B) reaffirmed but tight
Q2 2026 print = pivotal catalyst (Aug 2026)

🔵 Asymmetry — Favorable R/R

Base FV $22.30 vs current $16.78 = +33% upside
Bull case $28–32 (+71%); bear $11–15 priced
Military exclusivity = underpriced scarcity asset

{ "verdict_label": {"it": "Risk/Reward Favorevole", "en": "Favorable Risk/Reward"}, "verdict_text": {"it": "Dislocato post Q1 (−22%) malgrado EPS beat e guidance riaffermata. Bilancio solido (0.8x leverage), esclusiva militare US Army/Air Force come asset di scarsità sottoprezzato. Asymmetria 3.5x bull/bear.", "en": "Dislocated after Q1 (−22%) despite EPS beat and reaffirmed guidance. Solid balance sheet (0.8x leverage), US Army/Air Force exclusivity as underpriced scarcity asset. 3.5x bull/bear asymmetry."}, "bull_points": [ {"it": "Esclusiva US Army & Air Force (72 sedi) da aprile 2026, asset di scarsità non prezzato", "en": "US Army & Air Force exclusivity (72 sites) from April 2026, unpriced scarcity asset"}, {"it": "Margine op rettificato +210bps a 10.2%; net income +120% YoY in Q1 2026", "en": "Adj op margin +210bps to 10.2%; net income +120% YoY in Q1 2026"}, {"it": "Bilancio solido: leva netta 0.8x EBITDA, $361M liquidità totale", "en": "Solid balance sheet: net leverage 0.8x EBITDA, $361M total liquidity"} ], "bear_points": [ {"it": "Traffico cliente in calo, business mass-market esposto a recessione consumer", "en": "Customer traffic declining, mass-market business exposed to consumer recession"}, {"it": "Multipli a 7.3x sotto mediana peer; rischio di compressione se Q2 deludesse", "en": "Multiples at 7.3x below peer median; compression risk if Q2 disappoints"}, {"it": "Nessun buyback attivo nonostante ampia liquidità", "en": "No active buyback despite ample liquidity"} ], "risks": [ {"it": "Q2 2026 (agosto): test pivotale guidance FY26 e ripresa traffico", "en": "Q2 2026 (August): pivotal test of FY26 guidance and traffic recovery"}, {"it": "Concorrenza online (WRBY AI glasses) erode quota nei giovani consumatori", "en": "Online competition (WRBY AI glasses) erodes share among younger consumers"}, {"it": "Esposizione consumer discretionary; recessione macro = bear case −34%", "en": "Consumer discretionary exposure; macro recession = bear case −34%"} ] }

Sources & Disclaimer

Sources: National Vision Holdings Q1 2026 10-Q (SEC), Yahoo Finance, Investing.com, Simply Wall St, StockAnalysis.com, Finance.yahoo.com / Insider Monkey (Military contract announcement), Trefis, Tickeron, Morningstar. Market data — last verified close 2026-06-19: EYE $16.78, market cap ~$1.33B, 52W: $10.45–$30.02, 79.3M shares outstanding. Short interest ~8.5%. Net debt $165M (Q1 2026 EoP). FY26 guidance reaffirmed. ⚠️ This document is for informational purposes only and does not constitute financial or investment advice.